ABVX Abivax SA

DGAP-News: Abivax sichert sich nicht-verwässernde Finanzierung über EUR 15 Millionen von Kreos Capital

DGAP-News: Abivax sichert sich nicht-verwässernde Finanzierung über EUR 15 Millionen von Kreos Capital
DE
13/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Abivax SA

 PRESS RELEASE

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod...

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY OF OBEFAZIMOD IN ABTECT PHASE 3 INDUCTION TRIALS: RESULTS OF 8-WEEK THERAPY IN SUBSETS OF PATIENTS WITH AND WITHOUT PRIOR INADEQUATE RESPONSE TO ADVANCED THERAPIES to be presented Monday, October 6 at 10am CET Abivax manage...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch